ATS 2018 International Conference - Mobile

Pre-Clinical Characterization of iMod.Fc, an Immune-Modulatory Therapeutic with Potentially Broad Application in Interstitial Lung Diseases [Board No. 917]

Location: Board no. 917

Session Type: RAPiD: Rapid Abstract Poster Discussion Session

Sunday

May

20

9:15 AM

11:15 AM

Speaker(s)/Author(s)

John D. Mendlein

PhD
aTyr Pharma

Leslie Nangle

PhD
aTyr Pharma

Ryan A. Adams

PhD
aTyr Pharma

Minh-Ha T. Do

PhD
aTyr Pharma

Andrea Cubitt

PhD
aTyr Pharma

Marc Thomas

MS
aTyr Pharma

David King

PhD
aTyr Pharma

Darin Lee

PhD
aTyr Pharma

Kathleen Ogilvie

PhD
aTyr Pharma

Qinghao (Howard) Xu

PhD
aTyr Pharma

View Abstract

Pre-Clinical Characterization of iMod.Fc, an Immune-Modulatory Therapeutic with Potentially Broad Application in Interstitial Lung Diseases

Parent Sessions

A21 - CLINICAL AND MECHANISTIC STUDIES OF LUNG FIBROSIS...
05-20-2018 9:15 AM - 11:15 AM